Stockreport

Carisma Therapeutics Inc. (CARM) Reports Q2 Loss, Tops Revenue Estimates [Yahoo! Finance]

Carisma Therapeutics, Inc.  (CARM) 
PDF This compares to loss of $0.49 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 25%. [Read more]